Sign In
Buy NDAQ
$81.61
-0.88 (-1.07%)
At Close: Jun 24, 2026
Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
08:00am, Tuesday, 04'th Mar 2025
MONTREAL and CHARLOTTE, N.C., March 04, 2025 (GLOBE NEWSWIRE) -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST) (the “Company” or “Milestone”), today announced that the Company granted equity a
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05:00pm, Monday, 03'rd Mar 2025
SAN DIEGO, March 03, 2025 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company developing a potentially first-in-class and best-in-class WEE1
Charles & Colvard, Ltd. Receives Expected Nasdaq Notice Regarding Delayed Form 10-Q
04:45pm, Monday, 03'rd Mar 2025
RESEARCH TRIANGLE PARK, N.C. , March 3, 2025 /PRNewswire/ -- Charles & Colvard, Ltd.
Meiwu Technology Company Limited Received Nasdaq Notification Letter Regarding Bid Price Deficiency
04:15pm, Monday, 03'rd Mar 2025
Shenzhen, China, March 03, 2025 (GLOBE NEWSWIRE) -- Meiwu Technology Company Limited (“WNW” or the “Company”), (NASDAQ: WNW) announced today that on February 27, 2025, the Company received a n
Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:05pm, Monday, 03'rd Mar 2025
NEWTON, Mass. , March 3, 2025 /PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that the Company
Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
04:05pm, Monday, 03'rd Mar 2025
BOSTON, March 03, 2025 (GLOBE NEWSWIRE) -- Verve Therapeutics, a clinical-stage company developing a new class of genetic medicines for cardiovascular disease, today announced that on February 28, 202
New York, New York, March 03, 2025 (GLOBE NEWSWIRE) -- NewHold Investment Corp III (the “Company”), a newly organized special purpose acquisition company formed as a Cayman Islands exempted compan
Nasdaq Appoints Brandis DeSimone as New Head of East Coast Listings
10:40am, Monday, 03'rd Mar 2025
The appointment strengthens Nasdaq's commitment to supporting companies throughout their corporate lifecycle
BOSTON and LONDON, March 03, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics Plc (Nasdaq: AKTX), a biotechnology company developing next-generation precision bi-functional antibody drug conjugates (ADCs)
Nasdaq to power Wall Street ahead as March trading begins, bitcoin up on Trump reserve order
08:20am, Monday, 03'rd Mar 2025
US stock indexes are tipped to head higher on the first trading day of March, led by the tech-powered Nasdaq. S&P 500 futures pointed to a 0.5% rise, with Nasdaq 100 futures rising 0.7% and those f
Nasdaq Stockholm approved the delisting of Millicom (Tigo) SDRs and set the last day of trading on March 17, 2025
08:19am, Monday, 03'rd Mar 2025
Nasdaq Stockholm approved the delisting of Millicom (Tigo) SDRs and set the last day of trading on March 17, 2025 Luxembourg, March 3, 2025 – Millicom International Cellular S.A. (“Millicom” or
Biomea Fusion, Inc. Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
08:00am, Monday, 03'rd Mar 2025
REDWOOD CITY, Calif., March 03, 2025 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea”) (Nasdaq: BMEA), a clinical-stage diabetes and obesity medicines company, today announced that on March 3, 20
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
07:30am, Monday, 03'rd Mar 2025
CLEVELAND, March 03, 2025 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced it has granted equity awards to new non-executive employees who joined the Company. The equity awa
Neuphoria Therapeutics to Ring the Nasdaq Opening Bell on March 3rd, 2025
07:30am, Monday, 03'rd Mar 2025
BURLINGTON, Mass., March 03, 2025 (GLOBE NEWSWIRE) -- Neuphoria Therapeutics Inc. (Nasdaq: NEUP) (Neuphoria or Company), ”), a clinical-stage biotechnology developing impactful treatments for neurop
Wall Street legend says US stocks are in a bubble: 3 Nasdaq 100 shares to sell
01:11am, Monday, 03'rd Mar 2025
The Nasdaq 100 index surged to a record high of $22,220 in February and then suffered a harsh reversal to a low of $20,500 last week. This retreat happened as concerns about Donald Trump's tariffs and
